| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
6 companies
Jacqueline B Kosecoff is Director at ALHC, with reported holdings spanning 6 companies. Jacqueline B Kosecoff's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.1M at current prices.
Our model assigns Jacqueline B Kosecoff a below-average insider score of 44/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -3.6%.
Jacqueline B Kosecoff's largest disclosed position is in ALHC as Director, worth about $2.5M.
Jacqueline B Kosecoff has 50 Form 4 filings on record from May 2015 to May 2026, across 6 companies: Director at TriNet Group (TNET), 2020–2026; Director at Alignment Healthcare (ALHC), 2021–2026; Director at Houlihan Lokey (HLI), 2016–2025, and 3 more.
The 94 reported transactions were 37 stock awards, 28 option or other derivative awards, 14 gifts and 7 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $4.4M.
The largest open-market sale was 4,584 shares of STE at an average $231.53 on May 13, 2024, about $1.1M. Twelve months later STE was down 1%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | STE Steris Plc | Director | Sale+OE | 4,584 | $231.53 | $1,061,333.52 | - | +0.6% | -0.6% | |
| May 15, 2023 | STE Steris Plc | Director | Sale+OE | 4,657 | $212.56 | $989,891.92 | - | +8.7% | +11.9% | |
| Feb 10, 2022 | STE Steris Plc | Director | Sale+OE | 3,218 | $235.20 | $756,873.60 | - | -8.7% | -16.5% | |
| May 21, 2021 | STE Steris Plc | Director | Sale+OE | 3,121 | $192.59 | $601,073.39 | - | +13.0% | +19.5% | |
| Feb 12, 2020 | STE Steris Plc | Director | Sale+OE | 3,133 | $167.56 | $524,965.48 | -76.6% | - | - | |
| May 15, 2019 | STE Steris Plc | Director | Sale+OE | 3,609 | $132.22 | $477,181.98 | - | - | - |